Recent evidence suggests that arginine vasopressin (AVP)-dependent aquaporin-2 expression is modulated by the extracellular calcium-sensing receptor (CaSR) in principal cells of the collecting duct, but the signaling pathways mediating this effect are unknown. Using a mouse cortical collecting duct cell line (mpkCCD cl4 ), we found that increasing the concentration of apical extracellular calcium or treating with the CaSR agonists neomycin or Gd 3ϩ attenuated AVP-dependent accumulation of aquaporin-2 mRNA and protein; CaSR gene-silencing prevented this effect. Calcium reduced the AVP-induced accumulation of cAMP, but this did not occur by increased degradation of cAMP by phosphodiesterases or by direct inhibition of adenylate cyclase. Notably, the effect of extracellular calcium on AVP-dependent aquaporin-2 expression was prevented by inhibition of calmodulin. In summary, our results show that high concentrations of extracellular calcium attenuate AVP-induced aquaporin-2 expression by activating the CaSR and reducing coupling efficiency between V 2 receptor and adenylate cyclase via a calmodulindependent mechanism in cultured cortical collecting duct cells.
Aquaporins (AQP) facilitate water reabsorption across plasma membranes of renal epithelial cells. The fine-tuning of water reabsorption takes place along the collecting system, where water permeability is controlled by [8-arginine] vasopressin (AVP). An acute increase in AVP concentration enhances water permeability via V 2 receptors 1 by inducing AQP2 translocation from intracellular vesicles to the apical membrane. 2 Water exits the cells via basolateral AQP3 and AQP4. 3, 4 Conversely, a sustained increase of circulating AVP increases AQP2 and AQP3 abundance and consequently increases collecting duct (CD) water permeability. 5 The extracellular calcium-sensing receptor (CaSR), a seven-membrane-spanning G-proteincoupled receptor 6 that is expressed in renal epithelial cells, 7 is activated by extracellular Ca 2ϩ , Mg 2ϩ , and other polycations. 8 CaSR activation may lead to (1) reduced cAMP levels and protein kinase A (PKA) activity as a result of calcium-sensitive adenylate cyclase (AC) inhibition and phosphodiesterase activation 9 and (2) phospholipase C activation and ensuing activation of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK). 8 In the CD, CaSR is expressed in the apical membrane, where it senses luminal Ca 2ϩ , 10 and may antagonize effects of AVP on AQP2 subcellular localization and whole-cell expression. In inner medullary CD (IMCD), elevated luminal Ca 2ϩ blunts AVPinduced acute water permeability. 10 In addition, high concentrations of extracellular Ca 2ϩ attenuated forskolin-induced AQP2 plasma membrane targeting in cultured CD cells. 11 Moreover, AVP-induced water permeability, AQP2 apical membrane targeting, and protein expression all are decreased in CD of hypercalcemic rats. 12, 13 We investigated the mechanisms that account for modulated AQP2 expression by extracellular calcium in CD principal cells using the cortical CD (CCD) mpkCCD cl4 cell line exhibiting the major functional properties of CD principal cells. 14 
RESULTS

High Extracellular Calcium Attenuates AVP-Induced AQP2 Expression
We first examined the effect of extracellular calcium on AVPdependent AQP2 expression. AVP-treated cells were incubated for 3 to 24 h with either baseline or 5 mM apical calcium. Western blotting analysis showed that AVP-induced AQP2 protein expression was not affected during the first 8 h after calcium supplementation (Figure 1 , A, lanes 1 to 6, and B); however, AVP-dependent AQP2 protein accumulation decreased by 31 Ϯ 7.8% 24 h after apical calcium concentration was increased (Figure 1 , A, lanes 7 and 8, and B). No significant effect was produced by basolateral calcium supplementation (data not shown). Real-time PCR analysis showed that compared with baseline, 5 mM apical calcium attenuated AVPinduced AQP2 mRNA accumulation in a time-dependent manner ( Figure 1C ). This effect was significant after 8 h and persisted after 24 h of incubation (as percentage of decreased AQP2 mRNA content from baseline Ϯ SE; 8 h 20.1 Ϯ 7.9; 24 h 25.3 Ϯ 5.6). Elevated calcium did not affect P 0 mRNA content (data not shown), which was used as a loading control.
To determine whether extracellular calcium modulates AQP2 mRNA transcription or stability, we measured AQP2 mRNA decay in the presence of actinomycin D, which blocks de novo transcription. AVP-treated cells were incubated for 24 h with either 1 or 5 mM apical calcium and then treated for 3 or 5 h with 5 ϫ 10 Ϫ6 M actinomycin D. The extent of AQP2 mRNA decay after addition of actinomycin D was similar in cells incubated in the presence of either baseline or high apical calcium ( Figure 1D ).
The effect of high apical calcium on AQP2 expression did not result from impaired cell growth because transepithelial electrical resistance, an index of cell density and differentiation, was similar in cells incubated 24 h with either 1 or 5 mM apical calcium (as kOhm/cm 2 Ϯ SE; 1 mM Ca 2ϩ 1.52 Ϯ 0.15; 5 mM Ca 2ϩ 1.35 Ϯ 0.29).
CaSR Activation Mediates the Attenuation of AVPInduced AQP2 Expression by High Extracellular Calcium
To investigate the role of CaSR in modulated AVP-dependent AQP2 expression by extracellular calcium, we assessed the effect of the CaSR agonists neomycin 10 and gadolinium. 11 AVPtreated cells were incubated for 24 h with or without increasing concentrations of neomycin (100 to 500 M) or gadolinium (10 to 100 M) added to the apical medium. Both neomycin ( pression is independent of variations of CaSR expression because both CaSR mRNA and protein content remained unchanged after incubation with either 1 or 5 mM apical calcium ( Figure 3A ). The role of CaSR was further investigated by CaSR knockdown experiments. Both CaSR RNAi exhibited similar efficiencies and dramatically decreased CaSR mRNA and protein expression compared with scramble RNAi ( Figure 3B ). Increased apical calcium (5 mM) attenuated AVP-induced AQP2 mRNA expression by 24.2 Ϯ 1.7% in cells transfected with scramble RNAi, whereas the inhibitory effect of high apical calcium was abolished in cells transfected with CaSR RNAi ( Figure 3C ).
CaSR Activation Reduces the Efficiency of Coupling between V 2 Receptor and AC For assessment of the role of ERK and PKC in modulated AQP2 protein expression by extracellular calcium, AVPtreated cells were incubated for 24 h with either 1 or 5 mM apical calcium in the absence or presence of 10 Ϫ6 M GF109203X or U0126, which specifically inhibit PKC isozymes and the ERK activating kinase MEK-1, respectively. Neither GF109203X nor U0126 altered the attenuation of AVP-induced AQP2 expression by 5 mM apical calcium ( Figure 4 ). It should be mentioned that although U0126 efficiently prevents ERK activation in mpkCCD cl4 cells, 15 the efficacy of GF109203X has not been formally demonstrated in this model. calcium were preincubated at 37°C with 10 Ϫ9 M AVP for 24 h and then incubated in the continuous presence of AVP for another 24 h with 1 or 5 mM apical calcium. RNA or protein was then extracted and real-time PCR or Western blotting was performed as described in the Concise Methods section using primers or antibodies specific for CaSR, respectively. (B and C) Two days after transfection with either CaSR scramble RNAi (Scr) or CaSR RNAi, confluent mpkCCD cl4 cells grown on filters in culture medium containing baseline (1 mM) calcium were preincubated at 37°C with 10 Ϫ9 M AVP for 24 h and then incubated in the continuous presence of AVP for another 14 h with 1 or 5 mM apical calcium. RNA or protein was then extracted and real-time PCR or Western blotting was performed as described in the Concise Methods sections using primers or antibodies specific for CaSR, respectively (B), or primers specific for AQP2 (C). Na-KATPase ␣-subunit was used as a loading control for Western blotting, and representative immunoblots from two independent experiments are shown. CaSR and Na,K-ATPase ␣-subunit were detected as 140-and 110-kD bands, respectively. PCR results are expressed as a percentage of control values determined after incubation in the presence of 1 mM calcium (100%). Bars are means Ϯ SEM from six independent experiments. *P Ͻ 0.05.
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To assess the role of the PKA pathway, we analyzed the effect of cell-permeable, myristoylated PKI (Calbiochem, Darmstadt, Germany), a specific PKA inhibitor. AVP-treated cells were incubated for 24 h with 1 or 5 mM apical calcium in the absence or presence of 5 ϫ 10 Ϫ6 M PKI. PKI alone decreased AVP-dependent AQP2 mRNA accumulation by 31.5 Ϯ 5.3% ( Figure 5A) ; however, AQP2 mRNA abundance was not further decreased by 5 mM apical calcium.
We investigated whether high extracellular calcium impairs AVP-induced cAMP accumulation. Cells were first incubated for 24 h in the presence of 1 or 5 mM apical calcium and then challenged with 10 Ϫ9 M AVP for 30 to 60 min before measuring cellular cAMP in the absence of phosphodiesterase inhibitor. Figure 5B shows that AVP-induced increase of cellular cAMP from background levels (as pmol ϫ 10 6 cells/min Ϯ SE; 30 min 5.69 Ϯ 1.19; 60 min 5.44 Ϯ 0.82) was attenuated by more than 50% in cells exposed to 5 mM apical calcium (Figure 5B) .
The decreased cAMP accumulation in response to high extracellular calcium may result from a responsive deficiency of an initial step of AVP signaling (i.e., the V 2 receptor and AC). Real-time PCR analysis revealed similar V 2 receptor mRNA content in cells subjected to 1 or 5 mM apical calcium ( Figure  5C ). Similarly, elevated calcium did not alter the mRNA levels of AC types 3, 5, and 6 ( Figure 5C and data not shown) (i.e., the calcium-sensitive AC isoforms expressed in CD). 16 It should be mentioned that the expression levels of AC types 3 and 5 isoforms are, respectively, 3000-and 600-fold lower than the expression levels of AC type 6 in mpkCCD cl4 cells.
For assessment of whether extracellular calcium alters coupling between cAMP and PKA, cells were treated or not for 24 h with 10 Ϫ3 M 8Br-cAMP, which increased AQP2 mRNA expression by 11.66 Ϯ 1.5-fold. In contrast to untreated cells, high extracellular calcium did not alter AQP2 mRNA expression in the presence of 8Br-cAMP ( Figure 6A ).
For determination of whether high apical calcium attenuates AVP-induced AQP2 expression via increased cAMP degradation by phosphodiesterases, cells were preincubated for 24 h with baseline calcium in the absence or presence of 10 Ϫ9 M AVP and then incubated for 24 h with 1 or 5 mM apical calcium in the absence or presence of 10 Ϫ4 M 3-isobutyl-1-methylxanthine (IBMX), an inhibitor of phosphodiesterases. IBMX increased AQP2 mRNA levels in both the absence and the presence of AVP but did not prevent the attenuation of AVP-induced AQP2 mRNA accumulation by high apical calcium ( Figure 6B ).
For assessment of whether high apical calcium directly inhibits AC, cells were first preincubated for 24 h with 1 or 5 mM apical calcium and treated or not for another 24 h with 5 ϫ 10 Ϫ6 M forskolin, a direct activator of AC. Forskolin increased AQP2 mRNA expression 31.34 Ϯ 5.84-fold; however, 5 mM apical calcium did not alter AQP2 mRNA expression in the presence of forskolin ( Figure 6C ).
Recent experimental evidence indicates that calmodulin is required for AVP-induced cAMP accumulation in IMCD cells. 17 For assessment of whether calmodulin plays a role in the attenuation of AVP-induced AQP2 expression by high apical calcium, AVP-treated cells were incubated for 24 h with 1 or 5 mM apical calcium and in the absence or presence of either 10 Ϫ5 M W7 or 10 Ϫ5 M trifluoperazine, two structurally unrelated inhibitors of calmodulin. Inhibition of calmodulin did not alter AQP2 mRNA expression in the presence of baseline calcium ( Figure 7) ; however, both inhibitors prevented the attenuation of AVP-induced AQP2 mRNA accumulation induced by 5 mM apical calcium.
DISCUSSION
These results show that high concentrations of apical calcium attenuate AVP-induced AQP2 expression via activation of the CaSR and reduced coupling efficiency between V 2 receptors and AC activation in mpkCCD cl4 cells, a physiologically relevant and well-characterized CD principal cell model. 14, 18 Our observation that high apical calcium attenuates AVPinduced AQP2 expression suggests that decreased AQP2 protein abundance, reported in hypercalciuric rats, 12, 13 relies on a direct effect of luminal calcium acting on CD principal cells. The effect of extracellular calcium on AVP-dependent AQP2 protein expression is observed after a time lag of several hours and is preceded by an attenuation of AVP-induced AQP2 mRNA accumulation without decreased AQP2 mRNA stability. The effect of high apical calcium most likely results from diminished AVP-stimulated AQP2 gene transcription 18 ; however, actinomycin D is a general transcription inhibitor, and we cannot exclude that expression of a modulator of mRNA degradation might also be inhibited. Decreased AQP2 mRNA abundance was not observed in the inner medulla of hypercalcemic rats. 12, 13 This discrepancy may rely, at least in part, on the confounding effect of increased plasma AVP levels in response to hypercalcemia-induced polyuria. 12 Indeed, one can speculate that the same level of polyuria in normocalcemic rats would increase circulating AVP levels and thereby enhance renal AQP2 mRNA expression. In addition, the modest calcium-induced reduction in AVP-dependent AQP2 mRNA accumulation may have been overlooked by the Northern blot technique used in previous studies. 12, 13 Finally, the mechanisms of controlled AQP2 expression may differ between CCD and IMCD cells. Long-term modulation of AVP-dependent AQP2 expression by extracellular calcium occurs together with an extracellular calcium-induced reduction of cAMP-induced translocation of AQP2 to the plasma membrane. 11 Altogether, these observations indicate that extracellular calcium modulates both subcellular repartition and whole-cell expression levels of AQP2.
In mpkCCD cl4 cells, both neomycin and Gd 3ϩ , two CaSR agonists, 8 reproduced the antagonistic effect of extracellular calcium concentration on AVP-induced AQP2 expression. These CaSR agonists also antagonized the cAMP-induced acute increase of water permeability after translocation of AQP2 to the plasma membrane. 10, 11 Our results indicate that similar to native CD cells, mpkCCD cl4 cells express functional apical CaSR. 10 CaSR expression levels were independent of extracellular calcium, and knockdown of CaSR prevented the attenuation of AVP-induced AQP2 expres- Multiple signaling pathways are affected by CaSR. 8 Our findings suggest that the CaSR modulates AQP2 expression independent of PKC and ERK; however, we showed that modulated AQP2 expression by CaSR depends on calmodulin and thereby intracellular calcium in CCD cells. In addition, the effects of high extracellular calcium and a specific inhibitor of PKA were not additive. Taken together with impaired cAMP accumulation by high extracellular calcium, our observations suggest that CaSR controls AQP2 transcription by inhibiting the PKA pathway. This result is in agreement with that of a previous study that showed decreased agonist-induced cAMP accumulation in response to high extracellular calcium in CD8 cells 11 ; however, the effect of extracellular calcium on AVPinduced cAMP accumulation cannot be assessed in CD8 cells that do not express V 2 receptor.
Impaired AVP-induced cAMP accumulation in response to high extracellular calcium may result from decreased cAMP synthesis by AC and/or increased cAMP degradation by phosphodiesterases. 8, 9, 19 Our results indicate that phosphodiesterase activation does not mediate the effects of high apical calcium on AVP-dependent AQP2 expression. Moreover, 8Br-cAMP, a hydrolyzable, cell-permeable cAMP analog, and forskolin, a direct activator of AC, induced AQP2 expression equally well in the presence of baseline or high extracellular calcium concentrations. Our finding that IBMX potentiated Ϫ6 M forskolin, a direct activator of AC. After RNA extraction, real-time PCR was performed as described in the Concise Methods section using primers against AQP2. Results are expressed as a percentage of control values determined after 24 h of incubation in the presence of 1 mM calcium and in the absence of drugs (100%). Bars are means Ϯ SEM from four to eight independent experiments. *P Ͻ 0.05. the effect of AVP on AQP2 expression may explain the improvement of hypercalcemia-induced polyuria by phosphodiesterase inhibitors. 20 Consequently, inhibited cAMP generation by AC most likely accounts for the repressive effect produced by extracellular calcium on AVP-dependent cAMP accumulation. High extracellular calcium alters neither the expression levels of V 2 receptor nor any of the calcium-sensitive AC isoforms expressed in the CD. 16, 17 Taken together with the observation that direct activation of adenylyl cyclases stimulated equally well AQP2 expression in the presence of baseline or high extracellular calcium, our results suggest that extracellular calcium modulates coupling between the V 2 receptor and adenylyl cyclase. The finding that forskolin-induced AQP2 mRNA expression is not inhibited by high apical calcium contrasts with that of a previous study 11 in which high extracellular calcium was shown to antagonize forskolin-induced AQP2 trafficking. Possibly, different mechanisms may be involved in short-and long-term modulation of cAMP-dependent AQP2 expression by extracellular calcium. In IMCD cells, stimulation of calmodulin-dependent AC type 3 is required for AVPstimulated cAMP accumulation 17 ; however, AVP-dependent AQP2 expression was not altered by calmodulin inhibitors, and the expression levels of AC 3 are very low in mpkCCD cl4 cells. Therefore, modulated AVP-dependent AQP2 expression by extracellular calcium is most likely independent of inhibition of calmodulin-dependent adenylyl cyclase 3 in cultured CD cells.
In conclusion, we showed that long-term exposure of CD principal cells to high apical calcium attenuated AVP-dependent AQP2 expression via CaSR-induced inhibition of cellular cAMP generation. Modulated AVP-dependent AQP2 expression depended on calmodulin and was most likely mediated by altered coupling between the V 2 receptor and AC. On the basis of these results together with those demonstrating decreased AQP2 expression in hypercalcemic rats 12, 13 and reduced AQP2 apical targeting in cultured CD cells that were subjected to high extracellular calcium, 11 it is tempting to speculate that luminal CaSR activation in the CD reduces urinary concentration, which prevents calcium salt precipitation and nephrolithiasis. 21 
CONCISE METHODS
Cell Culture, Incubation, and Transfection mpkCCD cl4 cells (passages 20 to 32) were grown to confluence for 7 d as described previously. 14 Cells were then maintained in serum-free, hormone-deprived medium containing 1 mM calcium for another 48 h before use. Unless otherwise mentioned, cells were preincubated for 24 h with baseline calcium (1 mM) and 10 Ϫ9 M AVP to induce AQP2 expression. Cells were then incubated in the continuous presence of 10 Ϫ9 M AVP.
For transfection with RNAi, 4 ϫ 10 6 cells were transferred to electroporation cuvettes (Gene Pulser cuvette 0.4 cm; Bio-Rad, Hercules, CA) along with 400 l of culture medium supplemented with 10% serum and 1.2 mmol RNAi and electroporated (300 mV, 960 pF) using a Bio-Rad Gene Pulser. 22 Sense primers for RNAi (Invitrogen, Carlsbad, CA) targeting the CaSR were 5Ј-CAACAUGACU-CUGGGUAUAGGAUA-3Ј and 5Ј-CAAAGUCUCGGUUAGAUAG-GCAAUA-3Ј, and that for scramble RNAi (corresponding to the first RNAi) was 5Ј-CAGGUGGUGGAAGUGAUCCAGAACU-3Ј. Cells were seeded at a density that allows confluence without division and were then allowed to recover for 24 h in culture medium containing 10% serum. Transfected cells were then maintained in serum-free, hormone-deprived medium for another 48 h. Preliminary experiments showed that silencing is optimal and that cells develop domes, a marker of vectorial solute and water transport, 3 d after transfection.
Western Blot Analysis
After incubation, cells were lysed and proteins (20 g) were separated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Immobilon-P; Millipore, Bedford, MA) as described previously. 18 AQP2 and Na,K-ATPase ␣-subunit were detected using polyclonal rabbit antibodies at 1:20,000 dilution. 18 CaSR was detected using a polyclonal rabbit antibody at 1:100 dilution (H100; Santa Cruz Biotechnology, Santa Cruz, CA). The antigen-antibody complexes were detected by enhanced chemiluminescence (Amersham-Pharmacia Biotech, Little Chalfont, UK). Results were quantified using a video densitometer and ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Real-Time PCR Analysis
RNA extraction, reverse transcription, and real-time PCR analysis were performed as described previously. 23 Primers used for detection of mouse P 0 were 5Ј-AATCTCCAGAGGCACCATTG-3Ј and 5Ј-GT-TCAGCATGTTCAGCAGTG-3Ј, those for AQP2 were 5Ј-CTTCCTTC-GAGCTGCCTTC-3Ј and 5Ј-CATTGTTGTGGAGAGCATTGAC-3Ј, those for CaSR were 5Ј-CTGTTTTGAGTGTGCGGAGTGT-3Ј and 5Ј-TCATCCGGGCACTTGTCA-3Ј, those for vasopressin V 2 receptor were 5Ј-CGTGGGATCCAGAAGCTCC-3Ј and 5Ј-GGCTAGCCAGCAG-CATGA-3Ј, those for AC type 6 were 5Ј-GACCAAGGACTCTAAG-GCATTCC-3Ј and 5Ј-CACCCCGGTTGTCTTTGCT-3Ј, those for AC type 5 were 5Ј-TGGAGATGGGAATGGACATGA-3Ј and 5Ј-CGCG-CATGTTCACGTTCA-3Ј, and those for AC type 3 were 5Ј-TGTCAC-CGTGGCAAACAAGA-3Ј and 5Ј-TCCATGGTGCTCTGGGAAAT-3Ј. For each pair of primers, a dissociation plot resulted in a single peak, indicating that a single cDNA species was amplified. The signal was linearly related with the initial amount of cDNA, and the slope of the linear relation was comprised between Ϫ3 and Ϫ3 to 4, indicating that during each PCR cycle the starting material was amplified by a factor of two. Data were analyzed using ABI Prism software (Applied Biosystems, Foster City, CA), and P o was used as an internal standard. Fold difference in cDNA abundance (F) was calculated using the formula F ϭ 2 (Ct1 Ϫ Ct2)
, where Ct1 and Ct2 are the number of cycles required to reach the threshold of amplicon abundance for experimental and control conditions, respectively.
Measurement of Intracellular cAMP
Cells were homogenized in a buffer containing 50 mM Tris and 4 mM EDTA (pH 7.4), and cellular cAMP levels were measured in the absence of phosphodiesterase inhibitor using the Cyclic AMP ( 3 H) Sys-tem (Amersham Pharmacia Biotech). The radioactivity was then measured by liquid scintillation on 200-l aliquots containing bound cAMP. Results were expressed as pmol cAMP ϫ 10 6 cells Ϫ1 .
Statistical Analyses
Results are means Ϯ SEM from n independent experiments. Each experiment was performed in cells from the same passage. Statistical differences were assessed using the Mann-Whitney U test for comparison of two groups or the Kruskal-Wallis test for comparison of more than two groups. P Ͻ 0.05 was considered significant.
